Braidwell LP Invests $45.48 Million in Humana Inc. $HUM

Braidwell LP bought a new position in Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 114,500 shares of the insurance provider’s stock, valued at approximately $45,482,000. Humana makes up about 1.7% of Braidwell LP’s investment portfolio, making the stock its 17th biggest position.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Wilkerson Advisory Group LLC boosted its holdings in Humana by 24.6% during the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after buying an additional 33 shares in the last quarter. Bogart Wealth LLC increased its holdings in shares of Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares in the last quarter. Fiduciary Alliance LLC increased its holdings in shares of Humana by 0.9% in the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after buying an additional 49 shares in the last quarter. Sanctuary Advisors LLC lifted its position in shares of Humana by 1.6% during the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after acquiring an additional 52 shares during the last quarter. Finally, Horizon Investments LLC lifted its position in shares of Humana by 2.5% during the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock valued at $573,000 after acquiring an additional 55 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on HUM. William Blair assumed coverage on Humana in a report on Wednesday, May 20th. They issued an “outperform” rating on the stock. Cantor Fitzgerald upped their target price on Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a report on Tuesday, July 7th. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target for the company in a research report on Wednesday, July 29th. Leerink Partners raised Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target on the stock in a research note on Thursday, July 30th. Finally, Mizuho boosted their price objective on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $403.91.

Humana Trading Up 1.3%

Humana stock opened at $400.12 on Thursday. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market capitalization of $48.05 billion, a price-to-earnings ratio of 37.85, a P/E/G ratio of 2.59 and a beta of 0.74. The company has a 50 day moving average price of $387.50 and a 200 day moving average price of $293.70.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue was up 26.2% on a year-over-year basis. During the same period in the previous year, the business earned $6.27 EPS. Research analysts forecast that Humana Inc. will post 9 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th. Humana’s payout ratio is presently 33.49%.

Trending Headlines about Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Humana’s board declared a quarterly cash dividend of $0.885 per share, payable November 27, 2026, to shareholders of record October 30. The unchanged payout supports income-oriented investors and signals confidence in the company’s cash generation. The annualized dividend is $3.54 per share, with an indicated yield of approximately 0.9%. Humana Board Declares Payment of Quarterly Dividend to Stockholders
• Positive Sentiment: Humana appointed a new medical chief as it expands its use of artificial intelligence in healthcare operations. The initiative could improve care management and efficiency, although the financial benefits remain longer term. Humana Names New Medical Chief on AI Push
• Neutral Sentiment: Analysts set a price target of $403.91, broadly indicating that expectations are close to Humana’s current trading range rather than signaling substantial additional upside. Analysts Set Humana Price Target at $403.91
• Neutral Sentiment: The Humana Foundation awarded scholarships to 80 children of company employees. The program supports employee relations and corporate reputation but is unlikely to materially affect near-term earnings. Humana Foundation Names 2026 Scholarship Recipients
• Negative Sentiment: Humana reaffirmed FY 2026 EPS guidance of approximately $9.00, below the $9.15 analyst consensus. The gap may weigh on valuation and suggests continued earnings pressure. Humana Reaffirms 2026 Earnings Guidance
• Negative Sentiment: Humana is preparing exit notices affecting approximately 600,000 Medicare Advantage members. The reductions may improve profitability in underperforming markets, but they also highlight membership and regulatory pressures and could reduce future revenue. Humana Exit Notices Loom for 600,000 Medicare Advantage Members

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.